OPR - Delayed Quote • USD BHVN Oct 2024 30.000 call (BHVN241018C00030000) Follow 16.90 -2.10 (-11.05%) As of April 17 at 11:15 AM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for BHVN241018C00030000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: BHVN Independent Director of Biohaven John Childs Buys 3.2% More Shares Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN) Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN) Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares Biohaven Announces Pricing of $230 Million Public Offering of Common Shares Biohaven Announces Proposed Public Offering of Common Shares Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside? Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN) Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
